Get unlimited digital access to baltimoresun.com. $0.99 for 4 weeks.

Topics

BREAKING NEWS
Food and Drug Administration
Vaccinogen brings momentum on cancer vaccine research to Baltimore
Vaccinogen brings momentum on cancer vaccine research to Baltimore

Three and a half decades after Michael Hanna Jr. began exploring the concept of using the body's own immune system to fight cancer, the idea is driving Baltimore's latest biotechnology promise. The company Vaccinogen, drawing on research that Hanna began when he was director of a National Cancer Institute lab in Frederick, is developing a vaccine that uses colon cancer patients' own tumor cells to train their bodies to fight off a recurrence of the disease. The company moved to Baltimore from Frederick a week ago in search of skilled workers, high-tech connections and eventually, perhaps, space for a manufacturing facility. The move comes amid a surge in attention to...

Loading